[Usefulness of determining hepatic clearance of Tc-HEPIDA in the diagnosis and differential diagnosis of chronic diseases of the liver parenchyma].
Kuydowicz
J
J
Studniarek
M
M
Wojciechowski
A
A
Liniecki
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005260:Female; D006505:Hepatitis / Q000000981:diagnostic imaging* / Q000378:metabolism; D006521:Hepatitis, Chronic / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D007098:Imino Acids / Q000493:pharmacokinetics*; D008099:Liver / Q000000981:diagnostic imaging / Q000378:metabolism*; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics*; D011877:Radionuclide Imaging; D019780:Technetium Tc 99m Lidofenin
D007098:Imino Acids; D015609:Organotechnetium Compounds; D019780:Technetium Tc 99m Lidofenin
Przydatność oznaczania watrobowego klirensu osocza z 99mTc-HEPIDA w rozpoznawaniu i róznicowaniu przewlekłych chorób miazszu watroby.